Hologic Inc. Files 8-K on Financials
Ticker: HOLX · Form: 8-K · Filed: May 2, 2024 · CIK: 859737
Sentiment: neutral
Topics: sec-filing, financial-condition, results-of-operations
Related Tickers: HOLX
TL;DR
Hologic filed an 8-K, check it for financial updates.
AI Summary
Hologic, Inc. filed an 8-K on May 2, 2024, reporting on its financial condition and results of operations. The filing includes financial statements and exhibits related to the period ending May 2, 2024. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Hologic's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial results or forward-looking statements that would indicate a change in risk.
Key Players & Entities
- HOLOGIC INC (company) — Registrant
- DELAWARE (company) — State of Incorporation
- May 2, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Hologic, Inc.?
The primary purpose of this 8-K filing is to report on Hologic, Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on May 2, 2024.
What is Hologic, Inc.'s principal executive office address?
Hologic, Inc.'s principal executive offices are located at 250 Campus Drive, Marlborough, Massachusetts 01752.
What is Hologic, Inc.'s telephone number?
Hologic, Inc.'s telephone number is (508) 263-2900.
Under which section of the Securities Exchange Act of 1934 is this Current Report filed?
This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-02 16:01:27
Filing Documents
- ef20028283_8k.htm (8-K) — 29KB
- ef20028283_ex99-1.htm (EX-99.1) — 868KB
- 0001140361-24-023989.txt ( ) — 1075KB
- holx-20240502.xsd (EX-101.SCH) — 4KB
- holx-20240502_lab.xml (EX-101.LAB) — 21KB
- holx-20240502_pre.xml (EX-101.PRE) — 16KB
- ef20028283_8k_htm.xml (XML) — 4KB
02
Item 2.02 Results of Operations and Financial Condition. On May 2, 2024, Hologic, Inc. issued a press release announcing its financial results for the second quarter ended March 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise Cautionary Note Regarding Forward-Looking to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated May 2, 2024, of Hologic, Inc. announcing its financial results for the second quarter ended March 30, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 2, 2024 HOLOGIC, INC. By: /s/ Karleen M. Oberton Karleen M. Oberton Chief Financial Officer